Glyceryl trinitrate, an exogenous nitric oxide (NO) donor, and histamine, which causes NO formation in vascular endothelium, have been shown to trigger migraine attacks. However, it remains uncertain whether NO is involved in the subsequent phase of migraine attacks. To answer this question we studied the effect of L-NGmethylarginine hydrochloride (546C88), a NO-synthase inhibitor, on spontaneous migraine attacks. In a double-blind study design, 18 patients with migraine without aura randomly 546C88 (6 mg/ kg) or placebo (5% dextrose) iv given over 15 min for a single migraine attack (546C88: placebo, 15:3). Furthermore, 11 placebo-treated patients from previous double-blind trials with almost identical design were added to the placebo group in the statistical evaluation. Two hours after the infusion, 10 of 15 L-NGmethylarginine hydrochloride-treated patients experienced headache relief compared to 2 of 14 placebotreated patients (p=0.01). Symptoms such as phono- and photophobia were also significantly improved. A similar trend for nausea was not significant. We conclude that NO may be involved in the pain mechanisms throughout the course of spontaneous migraine attacks.
LassenLHThomsenLLKruuseCIversenHKOlesenJ.Histamine-1 receptor blockade does not prevent nitroglycerininduced migraine. Support for the NO-hypothesis of migraine.
Eur J Clin Pharmacol1996;
49:
335–9.
4.
LassenLHThomsenLLOlesenJ.Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine.
Neuro Report1995;
6:
1475–9.
5.
FeelischMNoackEA.Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
Eur J Pharmacol1987;
139:
19–30.
6.
RomaninCKukovetzWR.Guanylate cyclase activation by organic nitrates is not mediated via nitrite.
J Mol Cell Cardiol1988;
20:
389–96.
7.
TodaN.Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries.
Am J Physiol1990;
258:
311–7.
8.
FujiwaraMUsuiHKurahashiKJinoHShirahaseHMekataF.Endothelium-dependent contraction produced by acetylcholine and relaxation produced by histamine in monkey basilar arteries.
J Cardiovasc Pharmacol1992;
20:
114–6.
9.
OlesenJThomsenLLLassenLHOlesenIJ.The nitric oxide hypothesis of migraine and other vascular headaches.
Cephalalgia1995;
15:
94–100.
10.
LassenLHAshinaMChristiansenIUlrichVOlesenJ.Nitric oxide synthase inhibition in migraine.
Lancet1997;
349:
401–2.
11.
AltmanDG.Table B13. Random digits. In:
AltmanDG, ed.
Practical statistics for medical research.
London:
Chapman and Hall,
1991:
540–4.
12.
Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.
Cephalalgia1988;
8:
19–28.
13.
MathewNTDexterJCouchJFlamenbaumWGoldsteinJRapoportADose-ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine.
Arch Neurol1992;
49:
1271–6.
14.
ThomsenLLIversenHKOlesenJ.Increased cerebrovascular pCO2 reactivity in migraine with aura—transcranial Doppler study during hyperventilation.
Cephalalgia1995;
15:
211–5.
15.
Krabbe AÆOlesen J.Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms.
Pain1980;
8:
253–9.
16.
IversenHKOlesenJTfelt-HansenP.Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics.
Pain1989;
38:
17–24.
17.
IversenHKNielsenTHGarreKTfelt-HansenPOlesenJ.Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide mononitrate.
Eur J Clin Pharmacol1992;
42:
31–5.
ThomsenLLIversenHKBrinckTAOlesenJ.Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers.
Cephalalgia1993;
13:
395–9.
20.
LassenLHThomsenLLOlesenJ.Histamine induces both immediate and delayed headache in migraineurs due to H1 receptor activation. Support for the NO-hypothesis of migraine.
J Cereb Blood Flow Metab1995;
15:
168.
21.
MoncadaSPalmerRMJHiggsEA.Nitric oxide: physiology, pathophysiology and pharmacology.
Pharmacol Rev1991;
43:
109–42.
22.
GarthwaiteJ.Nitric oxide signalling in the nervous system.
Neurosciences1993;
5:
171–80.
23.
RadomskiMWPalmerRMJMoncadaS.Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.
Proc Natl Acad Sci USA1990;
87:
10043–7.
24.
NicholsFTMawadMMohrJPSteinBHilalSMichelsenWJ.Focal headache during balloon inflation in the internal carotid and middle cerebral arteries.
Stroke1990;
21:
555–9.
25.
FribergLOlesenJIversenHKSperlingB.Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
Lancet1991;
338:
13–17.
26.
ZwetlootCPCaekebekeJFVFerrariMD.Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine.
Stroke1993;
24:
1335–8.
27.
NosakiKMoskowitzMAMaynardKIKoketsuNDawsonTMBredtDSPossible origins and distribution of immunoreactive nitric oxide synthase containing nerve fibers in cerebral arteries.
J Cereb Blood Flow Metab1993;
13:
70–9.
28.
MoskowitzMA.Neurogenic inflammation in the pathophysiology and treatment of migraine.
Neurology1993;
43:
16–20.
29.
MellerSTGebhartGF.Nitric oxide (NO) and nociceptive processing in the spinal cord.
Pain1993;
52:
127–36.
30.
LücherTFVanhouttePM.The endothelium: modulator of cardiovascular functions.
Ann Arbor:
CRC Press,
1990.
